What is the 13F Pro Quality Score for ELUT?

13F Pro ranks ELUTIA INC. (ELUT) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ELUT's current score at https://13fpro.ai/company/ELUT (free sign-up required for the full ranking).

Where does 13F Pro source ELUT data?

All ELUTIA INC. fundamentals and ownership data come directly from SEC EDGAR. ELUTIA INC. files with the SEC under CIK 1708527. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ELUT in?

ELUTIA INC. (ELUT) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ELUT research updated on 13F Pro?

ELUT's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ELUTIA INC.(ELUT)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1708527 ELUT stock profile & AI dashboard →

13F Pro Quality Score

36.1/100

Rank #2,280 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ELUT Scores 36/100

exact factor attribution · 2026-09-11

ELUT's composite is driven by profitability and capital efficiency, held back by revenue growth and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Profitability

+7.5 pts

100th pct

Capital efficiency

+5.0 pts

100th pct

Earnings growth

+2.2 pts

95th pct

Shareholder dilution

-2.1 pts

9th pct

Institutional flow

-2.1 pts

8th pct

Earnings quality

-2.7 pts

23th pct

Scale

-6.2 pts

8th pct

Free cash flow

-6.5 pts

7th pct

Revenue growth

-8.9 pts

5th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ELUT Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for ELUTIA INC. (ELUT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ELUT at 36.1/100 on a 32-signal composite quality model, placing it at rank #2,280 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), ELUTIA INC. reports quarterly revenue of $2.4M, net income of $-7.6M, free cash flow of $-8.6M. Top institutional holders of ELUT by reported 13-F value include Nantahala Capital Management, AIGH Capital Management, Knollwood Investment Advisory, based on the most recent SEC filings. ELUT trades on the Nasdaq exchange and files with the SEC under CIK 1708527. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ELUT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ELUTIA INC. directly from SEC EDGAR. ELUTIA INC.'s 13F Pro composite quality score has ranged between 10 and 36 since 2026, currently 36.1 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Revenue

Q2 2026

$2.4M

Net Income

Q2 2026

$-7.6M

Free Cash Flow

Q2 2026

$-8.6M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-15.0% YoY

$12.3MFY 2025

FY22 $23.8MFY23 $24.7MFY24 $14.5MFY25 $12.3M

Net Income

+198.9% YoY

$53.4MFY 2025

FY22 $-32.9MFY23 $-37.7MFY24 $-53.9MFY25 $53.4M

Operating Income

+12.4% YoY

$-26.9MFY 2025

FY22 $-35.2MFY23 $-30.5MFY24 $-30.7MFY25 $-26.9M

EPS (Diluted)

+146.8% YoY

$0.87FY 2025

FY22 $-2.38FY23 $-2.07FY24 $-1.86FY25 $0.87

Total Assets

+72.6% YoY

$62.4MFY 2025

FY22 $68.8MFY23 $43.4MFY24 $36.1MFY25 $62.4M

Total Debt

—FY 2025

FY22 $24.3MFY23 $30.3MFY24 $26.4MFY25 —

Op. Cash Flow

-97.8% YoY

$-44.8MFY 2025

FY22 $-21.4MFY23 $-21.8MFY24 $-22.7MFY25 $-44.8M

Free Cash Flow

-100.3% YoY

$-46.7MFY 2025

FY22 $-22.0MFY23 $-22.1MFY24 $-23.3MFY25 $-46.7M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$12.3M -15.0%	$14.5M -41.5%	$24.7M +3.8%	$23.8M -49.7%	$47.4M +11.0%	$42.7M
Net Income	$53.4M +198.9%	$-53.9M -43.3%	$-37.7M -14.5%	$-32.9M -32.5%	$-24.8M -13.8%	$-21.8M
Operating Income	$-26.9M +12.4%	$-30.7M -0.6%	$-30.5M +13.3%	$-35.2M -52.8%	$-23.0M -69.4%	$-13.6M
EPS (Diluted)	$0.87 +146.8%	$-1.86 +10.1%	$-2.07 +13.0%	$-2.38 +0.0%	$-2.38 +73.2%	$-8.88
Total Assets	$62.4M +72.6%	$36.1M -16.8%	$43.4M -36.9%	$68.8M +2.5%	$67.2M -18.9%	$82.8M
Total Debt	—	$26.4M -13.1%	$30.3M +25.0%	$24.3M -29.9%	$34.6M -5.9%	$36.7M
Operating Cash Flow	$-44.8M -97.8%	$-22.7M -4.1%	$-21.8M -1.5%	$-21.4M -38.8%	$-15.4M -13.4%	$-13.6M
Free Cash Flow	$-46.7M -100.3%	$-23.3M -5.4%	$-22.1M -0.6%	$-22.0M -38.9%	$-15.8M -10.9%	$-14.3M

Get alerted when ELUT's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ELUTIA INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ELUT

Nantahala Capital Management, LLC
$3.1M3,184,947 sh
AIGH Capital Management LLC
$2.6M2,695,644 sh
Knollwood Investment Advisory, LLC
$2.5M2,556,724 sh
SILVERARC CAPITAL MANAGEMENT, LLC
$2.1M2,192,980 sh
VANGUARD CAPITAL MANAGEMENT LLC
$1.1M1,142,575 sh
PERKINS CAPITAL MANAGEMENT INC
$379.9K694,094 sh
GEODE CAPITAL MANAGEMENT, LLC
$279.4K285,229 sh
Corient Private Wealth LLC
$248.3K253,500 sh
RENAISSANCE TECHNOLOGIES LLC
$197.7K201,816 sh
VANGUARD FIDUCIARY TRUST CO
$169.0K172,446 sh

Fund	Value	Shares
Nantahala Capital Management, LLC	$3.1M	3,184,947
AIGH Capital Management LLC	$2.6M	2,695,644
Knollwood Investment Advisory, LLC	$2.5M	2,556,724
SILVERARC CAPITAL MANAGEMENT, LLC	$2.1M	2,192,980
VANGUARD CAPITAL MANAGEMENT LLC	$1.1M	1,142,575
PERKINS CAPITAL MANAGEMENT INC	$379.9K	694,094
GEODE CAPITAL MANAGEMENT, LLC	$279.4K	285,229
Corient Private Wealth LLC	$248.3K	253,500
RENAISSANCE TECHNOLOGIES LLC	$197.7K	201,816
VANGUARD FIDUCIARY TRUST CO	$169.0K	172,446

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ELUT on your watchlist

Track score changes the day ELUTIA INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ELUT a good stock to buy?

13F Pro's AI-powered analysis of ELUTIA INC. (ELUT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ELUT are available on the ELUT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ELUT is classified as a small company.

Which hedge funds own ELUT?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ELUT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ELUTIA INC.'s investment landscape.